查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198494

聽診器市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Stethoscope Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內（2022 年至 2027 年），聽診器市場預計將以 4.5% 的複合年增長率增長。

由於感染的傳播和與患者的直接接觸，COVID-19 爆發對市場的影響很大。 然而，隨著COVID-19的爆發，傳染病控制意識的提高，必須邏輯地權衡聽診器的好處和風險。 聽診器廣泛用於各種醫療行業，例如護士和呼吸治療師。 聽診器是最常用的聽腸音、肺音和心音的儀器。 然而，儘管使用頻率很高，但聽診器的診斷準確性有限。 一篇題為“關於 COVID-19 聽診器的辯論”的論文。 在 2021 年 2 月發表的文章“必要的工具或不必要的邪惡”中，許多研究報告了對可能成為感染媒介的聽診器的擔憂。 即使在對患者進行一次身體檢查後，聽診器污染也很嚴重。 污染風險最高的是聽診器的隔膜區域。 因此，我們開發了一種用觸摸式代替聽診器隔膜的分配器，以支持大流行後期的市場增長。 例如，2020年4月，印度理工學院孟買生物醫學工程與技術創新中心（BETIC）開發了一款支持藍牙的智能聽診器模塊“AYU DEVICES”，DBT——印度政府生物技術產業研究援助委員會（BIRAC）支持 該設備允許臨床醫生和醫護人員從安全距離聽診患者。 因此，疫情期間的這些發展對市場的增長產生了積極影響。

心血管和肺部疾病負擔的增加、患者平均就診次數的增加以及與設備相關的技術進步預計將在預測期內推動市場。 根據世界衛生組織 (WHO) 2021 年 7 月的更新，心血管疾病是全球死亡的主要原因。 其中包括冠心病、腦血管病、風濕性心髒病、先天性心髒病等疾病。 由於心血管疾病發病率的增加，由醫院和診斷中心的專家進行的初步檢查也在增加。 預計心血管疾病和相關並發症的高患病率將推動對聽診器的需求，擴大所研究市場的範圍並促進其在預測期內的增長。

此外，預計人口老齡化將對調查市場產生重大影響，因為 65 歲及以上的人更容易患慢性病，定期檢查的需求也會增加。 根據世界人口展望，2022年，全球65歲及以上人口將在2022年達到7.71億，2030年達到9.94億，2050年達到16億。預測。 此外，根據美國疾病控制與預防中心 2022 年 2 月更新的數據，2020 年美國有 83.4% 的成年人接受過醫生或其他醫療保健提供者的拜訪。 美國有 8.604 億患者，初級保健醫生就診率為 51.2%。 因此，預計在預測期內，增加平均就醫次數也將推動市場。

此外，主要市場參與者採用的各種策略預計將在預測期內推動市場增長。 例如，2021 年 6 月，3M 和 Eko 聯合推出了一款將 3M Littmann 技術與先進的 Eko 數字創新相結合的聽診器。 在英國和愛爾蘭，3M Littmann 的聽診器 CORE 數字聽診器迅速成為醫生的最愛。

因此，所有上述因素，例如醫院和診所的患者入院人數增加，心血管疾病預診斷增加，人口中與年齡相關的疾病等，預計將推高 然而，越來越多地採用先進的預檢設備可能會阻礙市場增長。

聽診器市場趨勢

電子聽診器領域有望佔據聽診器市場的主要市場份額

在按類型劃分的聽診器市場中，電子聽診器部分預計將佔據很大的市場份額。 電子聽診器可以將通過胸件獲得的聲學聲波轉換為電信號並將其放大以獲得最佳聽診效果。 此外，轉換後的電信號被數字化，可以進一步處理和傳輸。 該細分市場的增長歸因於慢性病負擔的增加、技術進步和產品發布。

此外，市場參與者的技術進步和創新也在推動這一細分市場的增長。 例如，2022 年 5 月，3M Littmann 宣布其“2022 Fast Company World Changing Ideas”表彰支持為共同利益而創新並解決社會不平等、氣候變化和公共衛生危機的公司、產品和舉措。宣布 3M Littmann CORE 數字聽診器在世界獎項計劃的健康類別中獲得了榮譽獎。

此外，波蘭遠程醫療創新公司 StethoMe 在最近與歐洲領先的遠程醫療提供商 MaQuestionMedicale 和 HomeDoctor 合作後，於 2020 年 4 月推出了人工智能無線聽診器。。 此類發布正在推動這一細分市場的增長。

因此，由於上述因素，市場有望在預測期內增長。

北美將在市場中佔有重要地位，預計在預測期內也會如此

由於人口老齡化、慢性病負擔增加、主要市場參與者的存在以及醫院數量的增加，北美預計將在全球聽診器市場中佔有重要的市場份額。

此外，該地區不斷增長的老年人口也在推動市場的增長。 例如，根據加拿大統計局 2021 年的人口普查，65 歲及以上的人口大約有 7,021,430 人，其中男性 3,224,680 人，女性 3,796,750 人。 老年人最容易患上各種疾病，因此必須進行健康檢查，從而推動整個醫療環境對聽診器的需求。

此外，主要市場參與者的各種關鍵戰略（例如合作夥伴關係和併購）預計將提振該地區的市場。 例如，2022年4月，Sanolla向FDA（食品藥品監督管理局）推出了具有AI功能的低頻聽診器“VoqX”，供美國臨床使用。 同樣，2021 年 6 月，HD Medical 宣布其旗艦產品 HD Steth 現在可以通過聽診器和醫療產品的領先在線零售商 Stethoscope.com 在線購買。 HD Medical 最近將 Stethoscope.com 介紹為美國主要的在線分銷合作夥伴。 此外，完善的醫療保健基礎設施的存在也極大地推動了該地區整體市場的增長。

鑑於這些因素，預計市場在預測期內將會增長。

聽診器市場競爭對手分析

聽診器市場競爭適中，由幾家大型企業組成。 從市場份額的角度來看，目前幾家大型企業佔據了市場主導地位。 目前主導市場的公司包括 3M、GF Health Products Inc.、Smiths Medical、Masimo Corporation 和 Medtronic plc。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 增加心血管和肺部疾病的負擔
    • 增加患者平均看醫生的次數
  • 市場製約因素
    • 先進的預檢測設備的採用正在取得進展
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按類型
    • 手動聽診器
    • 電子聽診器
  • 最終用戶
    • 醫院和診所
    • 門診手術中心
    • 家庭保健
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • 3M
    • Welch Allyn
    • GF Health Products Inc.
    • Medline Industries Inc.
    • American Diagnostic Corporation
    • Rudolf Riester GmbH
    • Cardionics
    • Smiths Medical
    • Heine Optotechnik GmbH & Co. KG
    • Eko Devices
    • Meditech Equipment Co., Ltd.
    • Contec Medical Systems

第7章 市場機會與今後動向

簡介目錄
Product Code: 68955

The Stethoscope Market is projected to register a CAGR of 4.5% during the forecast period (2022-2027).

The impact of the COVID-19 outbreak on the market was substantial owing to growing infections and direct contact with the patients. However, the advantages of the stethoscope must be logically weighed against the risks, as COVID-19 has sparked an era of enhanced infection control awareness. The use of the stethoscope is extensive among various medical specialists, such as nurses and respiratory therapists. The device is most frequently used for the auscultation of intestinal, lung, and heart sounds. The stethoscope's diagnostic accuracy was constrained despite its ubiquitous usage. An article titled "Controversies on the Stethoscope During COVID-19: A Necessary Tool or an Unnecessary Evil" published in February 2021 reported that numerous studies have raised concerns regarding stethoscopes as potential infection vectors. Contamination of the stethoscope is significant even after a single physical exam of the patient. The most common area at risk of contamination is the diaphragm of the stethoscope. On the other hand, a touch-free stethoscope diaphragm dispenser might be a good fit for this requirement, hence the development of such devices boosted the growth of the market in the latter phase of the pandemic. For instance, in April 2020, a Bluetooth-enabled Smart Stethoscope Module "AYU DEVICES" was developed by the Biomedical Engineering and Technology Innovation Centre (BETIC), IIT Bombay, and was supported by the Biotechnology Industry Research Assistance Council (BIRAC), DBT-Government of India. The device allowed clinicians and medical practitioners to auscultate patients from a safe distance. Thus, such developments amid the outbreak had a positive impact on the market's growth.

The growing burden of cardiovascular and pulmonary diseases, the increase in average patient visits to physicians, and technological advancements associated with the instruments are expected to drive the market over the forecast period. According to the July 2021 update by the World Health Organization, cardiovascular diseases are the leading cause of death around the world. Some of these include diseases such as coronary heart disease, cerebrovascular disease, rheumatic heart disease, congenital heart disease, and others. The preliminary testing done by the professionals in hospitals and diagnostic centers is increasing due to the increasing incidence of cardiovascular diseases. The high prevalence of cardiovascular diseases and complications associated with them are expected to drive demand for stethoscopes, which will expand the scope of the market studied and boost its growth over the forecast period.

Additionally, the geriatric population is expected to have a significant impact on the market studied as people aged over 65 are more prone to chronic diseases that will drive the demand for regular check-ups. According to the World Population Prospect, 2022, globally, in 2022, there were 771 million people aged 65 years or over, and the number is projected to reach 994 million by 2030 and 1.6 billion by 2050. Moreover, according to the Centers for Disease Control and Prevention data updated in February 2022, the percentage of adults who had a visit with a doctor or other health care professional in the United States was 83.4% in 2020. The number of visits in the United States was 860.4 million, and the percentage of visits made to primary care physicians was 51.2%. Therefore, the increase in average patient visits to physicians is also expected to drive the market during the forecast period.

Furthermore, various strategies adopted by the key market players are anticipated to drive market growth over the forecast period. For instance, in June 2021, 3M and Eko collaborated to launch a stethoscope that combines 3M Littmann technology with advanced Eko digital innovations. In the United Kingdom and Ireland, the 3M Littmann stethoscope, the CORE Digital Stethoscope, quickly became a popular choice among physicians.

Thus, all the aforementioned factors, such as increasing patient admissions in hospitals and clinics, increasing preliminary diagnosis of cardiovascular diseases, and age-related disorders in the population, are expected to boost the stethoscope market over the forecast period. However, the growing adoption of advanced preliminary testing devices may hamper the growth of the market.

Stethoscope Market Trends

Electronic Stethoscope Segment is Expected to Hold a Major Market Share in the Stethoscope Market

The electronic stethoscope segment is projected to hold a significant market share in the stethoscope market by type. Electronic stethoscopes convert the acoustic sound waves obtained through the chest piece into electrical signals, which can then be amplified for optimal listening. The converted electrical signals can also be digitalized for further processing and transmission. The growth of this segment is attributed to the growing burden of chronic diseases, advancements in technology coupled with the launch of products in the market.

The advancement in technology and innovation by the market players is also propelling the growth of the segment. For instance, in May 2022, 3M Littmann reported that the 3M Littmann CORE Digital stethoscope received honorable mention accolades in the health category of the 2022 Fast Company World Changing Ideas global awards program, recognizing companies, products, and initiatives that support innovation for the public good and tackle social inequality, climate change, and public health crises.

Furthermore, in April 2020, Polish telemedicine innovations company StethoMe rolled out its artificial intelligence wireless stethoscope following recent collaborations with major telemedicine providers MaQuestionMedicale and HomeDoctor in Europe. Such launches are propelling the growth of the segment.

Thus, owing to the abovementioned factors, the market segment is expected to project growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and is Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global stethoscope market, due to the increasing aging population, the rising burden of chronic diseases, the presence of major market players, and an increasing number of hospitals.

The growing geriatric population in the region is also propelling the growth of the market. For instance, as per the Statistics Canada 2021 census, there were around 7,021,430 people aged 65 years or above, out of which 3,224,680 were males and 3,796,750 were females. As the aged population is most vulnerable to various diseases, a health check-up has become mandatory, thereby driving the demand for stethoscopes across healthcare settings.

Furthermore, various key strategies by the key market players, such as partnerships, mergers, and acquisitions, are expected to boost the market in the region. For instance, in April 2022, Sanolla launched the AI-ready VoqX infrasound stethoscope with the Food and Drug Administration (FDA) for clinical usage in the United States. Similarly, HD Medical announced in June 2021 that its flagship product, HD Steth, is now available for purchase online through Stethoscope.com, one of the leading online stethoscope and medical product distributors. HD Medical recently introduced Stethoscope.com as a key online distribution partner in the United States. Furthermore, the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period.

Stethoscope Market Competitor Analysis

The stethoscope market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are 3M, GF Health Products Inc., Smiths Medical, Masimo Corporation, and Medtronic plc, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cardiovascular and Pulmonary Diseases
    • 4.2.2 Increase in Average Patient Visits to Physicians
  • 4.3 Market Restraints
    • 4.3.1 Growing Adoption of Advanced Preliminary Testing Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Manual Stethoscope
    • 5.1.2 Electronic Stethoscope
  • 5.2 By End Users
    • 5.2.1 Hospitals & Clinics
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Home Healthcare
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Welch Allyn
    • 6.1.3 GF Health Products Inc.
    • 6.1.4 Medline Industries Inc.
    • 6.1.5 American Diagnostic Corporation
    • 6.1.6 Rudolf Riester GmbH
    • 6.1.7 Cardionics
    • 6.1.8 Smiths Medical
    • 6.1.9 Heine Optotechnik GmbH & Co. KG
    • 6.1.10 Eko Devices
    • 6.1.11 Meditech Equipment Co., Ltd.
    • 6.1.12 Contec Medical Systems

7 MARKET OPPORTUNITIES AND FUTURE TRENDS